HRTX

HRTX Net Receivables

$89.57MQuarterly · USD

Period ending:

HRTX FY Net ReceivablesUSD
HRTX FY Net Receivables1987-12-31: $600.00K1988-12-31: $700.00K1989-12-31: $700.00K1990-12-31: $1.00M1991-12-31: $1.20M1992-12-31: $1.60M1993-12-31: $2.80M1994-12-31: $1.90M1995-12-31: $2.50M1996-12-31: $1.70M1997-12-31: $3.40M1998-12-31: $4.80M1999-12-31: $5.10M2000-12-31: $1.69M2001-12-31: $1.47M2002-12-31: $1.34M2003-12-31: $1.34M2004-12-31: $1.51M2005-12-31: $1.52M2006-12-31: $75.00K2007-12-31: $152.00K2008-12-31: $32.00K2009-12-31: $171.00K2010-12-31: $110.00K2011-12-31: $0.002012-12-31: $0.002013-12-31: $0.002014-12-31: $0.002015-12-31: $0.002016-12-31: $1.96M2017-12-31: $41.87M2018-12-31: $64.65M2019-12-31: $39.88M2020-12-31: $41.85M2021-12-31: $35.50M2022-12-31: $52.05M2023-12-31: $60.14M2024-12-31: $78.88M2025-12-31: $89.59M$89.59M$0.00
1987-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

HRTX net receivables history

Net amount expected from customer receivables. The available annual fiscal periods series contains 39 observations from Dec 31, 1987 to Dec 31, 2025.

Heron Therapeutics Inc Net Receivables — Annual fiscal periods (USD)
Period endingNet Receivables (USD)
89,587,000
78,881,000
60,137,000
52,049,000
35,499,000
41,850,000
39,879,000
64,652,000
41,874,000
1,960,000
0
0
0
0
0
110,000
171,000
32,000
152,000
75,000
1,519,000
1,506,000
1,340,000
1,340,000
1,468,000
1,691,132
5,100,000
4,800,000
3,400,000
1,700,000
2,500,000
1,900,000
2,800,000
1,600,000
1,200,000
1,000,000
700,000
700,000
600,000

Compare net receivables

All HRTX financial metrics · HRTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.